38 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
of death or disability) or (2) by the named executive officer for “good reason” (as such terms are defined in the named executive officer’s change … without cause (excluding by reason of death or disability) or (2) by the named executive officer for good reason, the named executive officer
8-K
EX-10.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
promulgated under the Securities Act.
2.12“Director” means a member of the Board.
2.13“Disability” means total and permanent disability as defined … in Code Section 22(e)(3), provided that the Administrator in its discretion may determine whether a permanent and total disability exists in accordance
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
immediately and without prior notice for Cause or due to Service Provider’s death or Disability. A termination shall be for “Cause” if it is for any … , of the Company. “Disability” means inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment
8-K
ATHA
Athira Pharma Inc
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
without “cause” (excluding by reason of death or disability) or (2) by Mr. Gengos for “good reason” (as such terms are defined in the Gengos Change … of death or disability) or (2) by Mr. Gengos for “good reason”, Mr. Gengos will receive the following benefits, subject to his timely signing
8-K
EX-10.3
t0k4c
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.2
puh9c
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
DEFC14A
lnqdudn6
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
0lim98
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
8-K
rg6eowo
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
8-K
EX-10.1
uec 0mwynm2h3kqe
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
8-K
g86j6awgu
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
EX-10.1
uidslv9bec
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
cu6qik t9a8iro1on
17 Jun 21
Departure of Directors or Certain Officers
9:32pm
DEF 14A
p2e83h
16 Apr 21
Definitive proxy
6:02am